Incidence of Infection Reported by COVID-19 in Attendees of a Commercial Music Concert

NCT04824625 | Completed

• 1 other identifier: StJordi-CoV
• Study Type: observational
• Target: 5,000
• Locations: 1 country
• Sites: 1

Brief Summary

From the beginning of the pandemic caused by SARS-CoV-2, most events with massive participants have been canceled due to being considered high-risk events for the SARS-CoV-2 transmission. It has been detected that asymptomatic people infected by SARS-CoV-2, are playing an important role in the contagious in these kinds of events. The economic losses arising from the closure of these activities, mainly those related to culture and musical performances are around 2.5 billion euros a Catalonia, and a considerable loss of jobs in this sector. Developing strategies of cribrate of infected people by SARS-CoV-2 asymptomatic or not diagnosticated and with a potential transmission of the virus is the key to perform cultural, sport, etc. massive events with all the security. The objective is to exclude infected people with a a high potential of transmission. It is needed to use versatile tests for this objective, so the test must have a high sensibility to detect infected people, the test has to be easy to manipulate without requiring a high technology of the laboratory hospitals, neither prolongated to obtain a result and that has a low cost. The rapid SARS-CoV-2 antigen screening tests are best suited for this purpose. On 27th March, a musical concert will be performed at Palau St Jordi (Barcelona) with 5000 attendees and with all the SARS-COV-2 safety measures by the "Secretary General of Health of the Generalitat de Catalunya" a (mandatory wearing a mask during the event, restricted outdoor areas of bar and smoking enhanced ventilation of the whole indoor area and avoiding queues.). This study wants to assess the incidence of SARS-CoV-2 infection reported to the health system among the attendees of this commercial concert during the 14 days following the event, also it will be evaluated the clinical evolution of the possible infections during the concert.

Conditions

Covid-19 (SARS-CoV-2)

Keywords

SARS-CoV-2; COVID-19; Coronavirus; Superspreading event; Concert

Outcome Measures

Primary Outcomes (2)

• Incidence rate of people with SARS-CoV-2

  Incidence rate of assistants with reported SARS-COV-2 14 dys after the event

  From day 1 to day 14 after the event

• Incidence rate of consultations in primary care centers

  Incidence rate of consultations in primary care centers about symptoms compatible with COVID-19 during the 14 days after the event

  From day 1 to day 14 after the event

Secondary Outcomes (4)

• Incidence rate of Hospital emergencies

  From day 1 to day 14 after the event

• Incidence rate of hospital admissions

  From day 1 to day 14 after the event

• Incidence rate of Intensive care units admissions

  From day 1 to day 14 after the event

• Incidence rate of mortality

  From day 1 to day 14 after the event

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All the commercial concert attendees, that are major of age (\>18 years old) and who have signed the informed consent to access their Medical records 14 days after the commercial concert.

You may qualify if:

• Adults (\> 18 years and under 65) attending the commercial music event scheduled at the Palau Sant Jordi
• Sign informed consent, including an authorization for the collection of data from the electronic health system of the Catalan System of Health on the notification of COVID-19 infection during the 14 days following the event or authorization to be contacted by telephone by the medical team, if necessary, for complete information on SARS-CoV-2 infection.

You may not qualify if:

• Minors (\<18 years)

Sponsors & Collaborators

• Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia: lead
• Festivals per la Cultura Segura AIE: collaborator

Study Sites (1)

Germans Trias i Pujol Hospital

Badalona, Barcelona, 08916, Spain

Location

MeSH Terms

Conditions

COVID-19; Coronavirus Infections

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 27, 2021
• First Posted: April 1, 2021
• Study Start: March 27, 2021
• Primary Completion: March 27, 2021
• Study Completion: April 10, 2021
• Last Updated: April 19, 2021

Record last verified: 2021-04

Locations

ES (1)